South Jordan Urgent Care Temporarily Closed

South Jordan Urgent Care is temporarily closed. Please disregard any wait time currently displayed for South Jordan Urgent Care and visit another University of Utah Health urgent care location for care. View urgent care locations 

Christopher B. Hansen
( out of 4533 reviews )

Christopher B. Hansen, MD

Languages spoken: English, French

Clinical Locations

Primary Location

Midvalley Health Center Dermatology

Dermatology
243 East 6100 South
Murray , UT 84107
801-581-2955
Get Directions

Christopher B. Hansen, MD has specialized expertise in the evaluation and treatment of rheumatic skin diseases such as lupus erythematosus, dermatomyositis, and scleroderma. He is board certified in Dermatology. Dr. Hansen’s main clinical focus is the medical management of connective tissue diseases that involve the skin as well as common skin disorders such as acne, rashes, and skin cancer. Dr. Hansen runs the UVA-1 phototherapy program in the Department of Dermatology. UVA-1 phototherapy is primarily used to treat patients with sclerosing skin disorders like morphea.

Specialties

Board Certification

American Board of Dermatology (Dermatology)

Patient Rating

Patients consistently describe Dr. Hansen as caring, attentive, and thorough. Many comment that he listens without rushing, explains diagnoses and treatment options clearly, and demonstrates strong medical knowledge and professionalism. Reviewers frequently praise his compassionate bedside manner, willingness to address concerns, and the trust they place in his ongoing care. Several patients say they would recommend him to family and friends.

Generated via Patient Reviews

5.0 /5
( out of 4533 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

Christopher B. Hansen, MD has specialized expertise in the evaluation and treatment of rheumatic skin diseases such as lupus erythematosus, dermatomyositis, and scleroderma. He is board certified in Dermatology. Dr. Hansen’s main clinical focus is the medical management of connective tissue diseases that involve the skin as well as common skin disorders such as acne, rashes, and skin cancer. Dr. Hansen runs the UVA-1 phototherapy program in the Department of Dermatology. UVA-1 phototherapy is primarily used to treat patients with sclerosing skin disorders like morphea.

Board Certification and Academic Information

Academic Departments Dermatology -Professor (Clinical)
Board Certification
American Board of Dermatology (Dermatology)

Education history

Chief Resident Dermatology - University of Texas Southwestern Chief Resident
Residency Dermatology - University of Texas Southwestern Medical School Resident
Internship Internal Medicine - University of Utah School of Medicine Intern
Research Fellow Dermatology - University of Utah - Dermatology Research Fellow
Professional Medical Medicine - University of Utah M.D.
Undergraduate French - University of Utah B.A.

Selected Publications

Journal Article

  1. Seifert RM, Noot CH, Sahni VN, Jimenez A, Gray L, Hopkins ZH, Frech TM, Hansen CB (2025). Ultraviolet A1 Phototherapy for Improvement of Hand Function in Scleroderma: A Blinded Prospective Study. Br J Dermatol.
  2. Seifert RM, Noot CH, Issa NT, Hull CM, Rhoads JLW, Clarke JT, Hansen CB, Zone JJ, Hopkins ZH (2026). Durability of Conventional Immunosuppressants in the Treatment of Oral Lichen Planus. J Clin Aesthet Dermatol, 18(12), 45-49.
  3. Seifert RM, Teames CR, Sahni V, Noot C, deShazo RA, Powell DL, Rhoads JLW, Clarke JT, Hansen CB, Zone JJ, Hull CM, Hopkins ZH (2025). The impact of allergen avoidance on oral lichen planus: A retrospective cohort-based comparison. J Am Acad Dermatol.
  4. Stone CJ, Broadbent E, Sahni VN, Gray L, Clarke JT, Hansen CB, Rhoads JLW, Zone JJ, Hull CM, Wu YP, Kean J, Secrest AM, Hopkins ZH (2025). Use of the Connor-Davidson Resilience Scale in a complex medical dermatology clinic: Cross-sectional study evaluating associations between resilience, health-related quality of life, and mental health. . J Am Acad Dermatol, S0190-9622(25)00389-5. doi: 10.1016/j.jaad.2025.02.082(1), 252-255.
  5. Sahni V, Teames C, Seifert R, Conley M, deShazo R, Powell D, Rhoads JLW, Clarke JT, Hansen CB, Zone JJ, Hull CM, Hopkins ZH (2025). The association between skin allergy testing and oral squamous cell carcinoma in oral lichen planus: a retrospective cohort study. Arch Dermatol Res, 317(1), 207.
  6. Esquivel ACF, Hansen CB (2024). Neurosensory symptoms and muscle cramping in morphea: A cross-sectional study and review. Skin Health Dis, 4(6), e453.
  7. Herron E, Powell D, Hansen, C (2024). Drug-induced dermatomyositis following COVID 19 vaccination. Dermatol Online J, 30(2).
  8. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2024). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194.
  9. Marcelus C, Jimenez A, Zussman J, Hansen CB, Sontheimer RD (2022). Questions raised by a case of adult-onset linear nodular scleroderma. Dermatol Online J, 28(5).
  10. Overbury RS, Stoddard GJ, Pupaibool J, Hansen CB, Lebiedz-Odrobina D (2021). The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers' opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle. BMC Health Serv Res, 21(1), 913.
  11. Beshay A, Zussman J, Hansen C (2020). Recurrent erythematous patch on the upper arm. JAAD Case Rep, 6(12), 1214-1216.
  12. Winchester D, Duffin KC, Hansen C (2012). Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus. Lupus, 21(9), 1007-10.
  13. Hansen CB, Dahle KW (2012). Cutaneous lupus erythematosus. Dermatol Ther, 25(2), 99-111.
  14. Gammon B, Hansen C, Costner MI (2011). Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus. J Am Acad Dermatol, 65(4), 717-721.e2.
  15. Lowe GC, Henderson CL, Grau RH, Hansen CB, Sontheimer RD (2011). A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol, 164(3), 465-72.
  16. Hansen CB, Callen JP (2010). Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea/scleroderma. Dermatol Ther, 23(4), 341-9.

Review

  1. Sahni VN, Yim R, Amanullah A, Sahni D, Powell D, deShazo R, Rhoads JLW, Clarke JT, Hansen CB, Zone JJ, Hull CM, Hopkins ZH (2025). An Allergy-Based Approach to Orofacial Granulomatosis: A Narrative Review. [Review]. Dermatitis.

Case Report

  1. Teames C, Florell SR, Hansen C (2025). A novel presentation of calcinosis cutis of the scalp in adult dermatomyositis. Dermatol Online J, 31(1).
  2. Shah A, Bowen A, Hansen C (2020). Multifocal periungual granulation tissue related to ibrutinib therapy. JAAD Case Rep, 6(2), 149-151.

Letter

  1. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561.
  2. Gonzalez CD, Hansen C, Clarke JT (2019). Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study. [Letter to the editor]. J Am Acad Dermatol, 81(3), 859-860.